Domestic pharmaceutical firms mull increasing R&D spending in 2004

Amid gloomy prospects that Korea's economy would hardly pick up until mid-2004, some of major domestic pharmaceutical firms are determined to achieve their revenue targets in 2004 by giving priority to R&D sector more recruitments of talented researchers, substantial increase in R&D spending, more strengthened R&D capability through strategic alliances with biopharmaceutical firms and academia...